IQVIA HOLDINGS INC. Increase (Decrease) in Deferred Revenue
IQVIA HOLDINGS INC. (IQV) reported Increase (Decrease) in Deferred Revenue of -$1.00 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-10-25
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was $44.00M.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was $6.00M.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$51.00M.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for fiscal 2017 was -$104.00M, a 300.00% decline from fiscal 2016.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for fiscal 2016 was $52.00M, a 3.70% decline from fiscal 2015.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for fiscal 2015 was $54.00M, a 170.00% increase from fiscal 2014.
- IQVIA HOLDINGS INC. increase (decrease) in deferred revenue for fiscal 2014 was $20.00M, a 72.17% decline from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2018-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $50.00M derived: sum of 2 quarters · filed 2018-10-25 | -$1.00M 10-Q · filed 2018-10-25 | ||
| 2018-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$45.00M 10-Q · filed 2018-07-27 | |||
| 2018-03-31 | -$51.00M 10-Q · filed 2018-05-04 | ||||
| 2017-12-31 | -$104.00M 10-K · filed 2018-02-16 | ||||
| 2016-12-31 | $52.00M 10-K · filed 2018-02-16 | ||||
| 2015-12-31 | $54.00M 10-K · filed 2018-02-16 | $53.85M 10-K · filed 2016-02-11 | |||
| 2014-12-31 | $20.00M 10-K · filed 2017-02-16 | $19.94M 10-K · filed 2015-02-12 | |||
| 2013-12-31 | $71.85M 10-K · filed 2016-02-11 | ||||
| 2012-12-31 | $54.50M 10-K · filed 2015-02-12 | ||||
| 2011-12-31 | -$52.42M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |